Elisabetta Dejana

Uppsala University — Sweden

Medicine · Health Sciences

127h-index57.6kcitations566works1.52yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cell Adhesion Molecules Research(150), Angiogenesis and VEGF in Cancer(114), Wnt/β-catenin signaling in development and cancer(72), Barrier Structure and Function Studies(51), Kruppel-like factors research(48)

Publications565 total

Introduction to Endothelial Cell Pathophysiology and Angiogenesis
2026
BMI1 Inhibition Improves Lesion Burden in Cerebral Cavernous Malformations
Circulation·2024· 3 cited
GPR126 is a specifier of blood-brain barrier formation in the mouse central nervous system
Journal of Clinical Investigation·2024· 3 citedOpen Access
Expression of Concern: Expression of junctional adhesion molecule-A prevents spontaneous and random motility
Journal of Cell Science·2024Open Access
Circulating biomarkers in familial cerebral cavernous malformation
EBioMedicine·2023· 15 citedOpen Access
Supplemental figures 1-6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Supplemental figures 1-6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Table and material & methods from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
FigS1,FigS2,FigS3,FigS4,FigS5,FigS6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Data from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Table and material & methods from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Data from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
FigS1,FigS2,FigS3,FigS4,FigS5,FigS6 from Targeting Vascular Endothelial-Cadherin in Tumor-Associated Blood Vessels Promotes T-cell–Mediated Immunotherapy
2023Open Access
Supplementary Figure 2 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 1 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 5 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 5 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 2 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 1 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
Supplementary Figure 3 from Inactivation of Junctional Adhesion Molecule-A Enhances Antitumoral Immune Response by Promoting Dendritic Cell and T Lymphocyte Infiltration
2023Open Access
page 1 of 29Next →

Frequent Co-authors

Maria Grazia Lampugnani(14), Monica Corada(10), Fabrizio Orsenigo(8), Adriana Zanetti(5), Alberto Mantovani(5), Luigi Ruco(4), F Breviario(4), Giovanna Balconi(4), Donald M. McDonald(4), Stefan Liebner(4), Ferruccio Breviario(4), Peter Carmeliet(3), Holger Gerhardt(3), Costanza Giampietro(3), Anna Cattelino(3), Inés Martín-Padura(2), Antonella Stoppacciaro(2), Gianfranco Bazzoni(2), Mieke Dewerchin(2), Peter Bałuk(2)